جميع الدراسات
نشط غير مجندالمرحلة 2تدخلي

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

This study is for people who have Generalized Myasthenia Gravis (MG), a condition that causes muscle weakness. Researchers are testing a new treatment called Descartes-08 CAR T-cells. This is a Phase IIb study, which means it's an early stage to see if the treatment is safe for people and if it starts to show benefits. The study will look at how well people with MG respond to this new treatment and if there are any side effects. Both people who test positive or negative for certain antibodies related to MG can take part. The main goal is to find out if Descartes-08 could be a helpful new option for managing generalized MG.

نظرة سريعة

الحالة
نشط غير مجند
المرحلة
المرحلة 2
الراعي
Cartesian Therapeutics
الهدف من التسجيل
30
ابدأ
04 Dec 2019
التاريخ المتوقع للانتهاء
31 مارس 2026

ما هو موضوع هذه الدراسة؟

This study is exploring a new type of treatment called Descartes-08 CAR T-cells for people who have a condition called Generalized Myasthenia Gravis (MG). MG is a long-term condition that causes muscle weakness and tiredness. This happens because the body's own immune system accidentally attacks the connections between nerves and muscles.

Descartes-08 is a special kind of treatment that uses your own immune cells, called T-cells, which are then modified in a lab to specifically target and clear out certain cells thought to be involved in MG. The aim is to calm down the immune system's attack on the muscles. This particular study is in an early stage, known as Phase IIb, which means it's being tested to see how safe it is for people with MG and if it starts to show signs of being effective in improving their condition.

The researchers are keen to see if this new approach can help reduce the symptoms of MG and improve the quality of life for those living with it. While it's an investigational treatment, the hope is that it could offer a new way to manage generalized MG for some people in the future.

النقاط الرئيسية

  • This study is testing a new treatment called Descartes-08 for Generalized Myasthenia Gravis.
  • It's an early-stage study (Phase IIb) to check for safety and if it helps symptoms.
  • Adults aged 18 and over with Generalized MG can be considered.
  • Both 'seropositive' and 'seronegative' MG patients are included.
  • You cannot participate if pregnant, breastfeeding, or have other serious uncontrolled illnesses.

من قد يكون مؤهلاً؟

To be considered for this study, you need to be at least 18 years old and have been diagnosed with Generalized Myasthenia Gravis. Your doctor must also believe that you need ongoing medication to control your condition. Interestingly, this study includes people with MG whether they test positive or negative for certain common blood markers sometimes used to diagnose MG.

However, some people won't be able to join. For example, if you have another serious long-term illness that isn't under control, and the study doctor thinks it might make taking part risky for you. Also, if you are pregnant or breastfeeding, unfortunately, you wouldn't be able to participate in this study.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Do you have a diagnosis of Generalized Myasthenia Gravis?
  3. Does your doctor think you need medication for your MG?
  4. Are you NOT currently pregnant or breastfeeding?
  5. Do you NOT have any other major uncontrolled chronic illnesses?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

While the detailed plan for participation isn't fully described, usually taking part in a clinical trial involves a number of steps. You would first have screening appointments to check if you meet all the study's requirements. If you qualify, you would receive the Descartes-08 treatment. This type of treatment often involves collecting your specific immune cells, sending them away to be specially prepared, and then giving them back to you.

After treatment, you would likely have regular follow-up visits to check on your health, how you're responding to the treatment, and to look for any side effects. These visits might include blood tests, physical examinations, and questionnaires about your symptoms and how you are generally feeling. The exact number and frequency of visits, as well as the total length of your involvement in the study, would be fully explained to you by the study team.

المخاطر والفوائد المحتملة

Participating in this study might offer a potential benefit by giving you access to a new treatment for Generalized Myasthenia Gravis that isn't widely available yet. It could potentially improve your symptoms. However, like all new treatments, there are potential risks and side effects that are not yet fully known. The study team will monitor you closely for any reactions or complications. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

المواقع (15)

  • Profound Research
    الرمز البريدي المؤكد
    كارلسباد، الولايات المتحدة
  • جامعة كاليفورنيا إيرفين
    الرمز البريدي المؤكد
    إرفاين، الولايات المتحدة
  • جامعة كولورادو حرم أنشوتز الطبي
    الرمز البريدي المؤكد
    أورورا، الولايات المتحدة
  • SFM Clinical Research, LLC
    الرمز البريدي المؤكد
    بوكا راتون، الولايات المتحدة
  • Neurology Associates, P.A.
    الرمز البريدي المؤكد
    أورلاندو، الولايات المتحدة
  • جامعة جنوب فلوريدا
    الرمز البريدي المؤكد
    تامبا، الولايات المتحدة
  • University of Augusta
    الرمز البريدي المؤكد
    أوغوستا، الولايات المتحدة
  • معهد أبحاث مركز جامعة كانساس الطبي
    الرمز البريدي المؤكد
    كانساس سيتي، الولايات المتحدة
  • Dent Neurologic Institute
    الرمز البريدي المؤكد
    Amherst, United States
  • University of North Carolina
    الرمز البريدي المؤكد
    تشابل هيل، الولايات المتحدة
  • جامعة أوريغون للصحة والعلوم
    الرمز البريدي المؤكد
    بورتلاند، الولايات المتحدة
  • جامعة بنسلفانيا
    الرمز البريدي المؤكد
    فيلادلفيا، الولايات المتحدة

أسئلة شائعة

What is Generalized Myasthenia Gravis?

It's a long-term condition that causes weakness in muscles throughout your body, as your immune system mistakenly attacks nerve-muscle connections.

What are 'CAR T-cells'?

CAR T-cells are a special type of treatment where your own immune cells are modified to find and fight certain other cells in your body.

What does Phase IIb mean for a study?

It means the study is an early stage to check if the new treatment is safe for people and if it starts to show benefits for the condition.

Will I get 'Descartes-08' if I join?

If you meet all the study's requirements and are accepted, you will receive the Descartes-08 treatment as part of the study.

Can I join if I'm already on other MG medicines?

Yes, if your doctor thinks you need ongoing immunosuppressive medications for your MG, you can still be considered for the study.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.